Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA013696
NIAMS NIH HHS
Grant: P30 AR069632
NCI NIH HHS
Grant: R01 CA164309
National Institutes of Health
Grant: 3P30CA013696-21S1
CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 5P30AR069632-04
Columbia University Skin Disease Resource-Based Center (epiCURE)
National Institutes of Health
Grant: 5R01CA164309-04
Enhancing the vaccinal effect of antitumor antibodies
FWCI
0.36
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals